Other Species / Isoforms
  EIF5 (human)      LTP 

LTP (Low Throughput Papers) : The number of records in which this modification site was determined using methods other than discovery mass spectrometry.

  HTP 

HTP (High Throughput Papers): The number of records in which this modification site was assigned using ONLY proteomic discovery mass spectrometry.

 
S2-p
______MsVNVNRsV
0 1
EIF5 (human) ______MsVNVNRsV S2-p
EIF5 (mouse) ______MsVNVNRSV S2-p
EIF5 (rat) ______MSVNVNRSV S2
S8-p
MsVNVNRsVsDQFyR
0 2
EIF5 (human) MsVNVNRsVsDQFyR S8-p
EIF5 (mouse) MsVNVNRSVsDQFYR S8
EIF5 (rat) MSVNVNRSVsDQFYR S8
S10-p
VNVNRsVsDQFyRyK
Upstream
0 22
Treatment
  • nocodazole
EIF5 (human) VNVNRsVsDQFyRyK S10-p
EIF5 (mouse) VNVNRSVsDQFYRYK S10-p
EIF5 (rat) VNVNRSVsDQFYRYK S10-p
Y14-p
RsVsDQFyRyKMPRL
0 1
EIF5 (human) RsVsDQFyRyKMPRL Y14-p
EIF5 (mouse) RSVsDQFYRYKMPRL Y14
EIF5 (rat) RSVsDQFYRYKMPRL Y14
Y16-p
VsDQFyRyKMPRLIA
0 1
EIF5 (human) VsDQFyRyKMPRLIA Y16-p
EIF5 (mouse) VsDQFYRYKMPRLIA Y16
EIF5 (rat) VsDQFYRYKMPRLIA Y16
K24-ac
KMPRLIAkVEGkGNG
0 2
EIF5 (human) KMPRLIAkVEGkGNG K24-ac
EIF5 (mouse) KMPRLIAKVEGkGNG K24
EIF5 (rat) KMPRLIAkVEGKGNG K24-ac
K24-ub
KMPRLIAkVEGkGNG
0 1
EIF5 (human) KMPRLIAkVEGkGNG K24-ub
EIF5 (mouse) KMPRLIAKVEGkGNG K24
EIF5 (rat) KMPRLIAKVEGKGNG K24
K28-ac
LIAkVEGkGNGIkTV
0 2
EIF5 (human) LIAkVEGkGNGIkTV K28-ac
EIF5 (mouse) LIAKVEGkGNGIkTV K28-ac
EIF5 (rat) LIAkVEGKGNGIKTV K28
K33-ac
EGkGNGIkTVIVNMV
0 3
EIF5 (human) EGkGNGIkTVIVNMV K33-ac
EIF5 (mouse) EGkGNGIkTVIVNMV K33-ac
EIF5 (rat) EGKGNGIKTVIVNMV K33
K55-ac
RPPTYPTkYFGCELG
0 19
EIF5 (human) RPPTYPTkYFGCELG K55-ac
EIF5 (mouse) RPPTYPTKYFGCELG K55
EIF5 (rat) RPPTYPTKYFGCELG K55
K55-ub
RPPTYPTkYFGCELG
0 6
EIF5 (human) RPPTYPTkYFGCELG K55-ub
EIF5 (mouse) RPPTYPTkYFGCELG K55-ub
EIF5 (rat) RPPTYPTKYFGCELG K55
K70-ub
AQTQFDVkNDRYIVN
0 1
EIF5 (human) AQTQFDVkNDRYIVN K70-ub
EIF5 (mouse) AQTQFDVKNDRYIVN K70
EIF5 (rat) AQTQFDVKNDRYIVN K70
K95-ub
MLDGFIKkFVLCPEC
0 1
EIF5 (human) MLDGFIKkFVLCPEC K95-ub
EIF5 (mouse) MLDGFIKKFVLCPEC K95
EIF5 (rat) MLDGFIKKFVLCPEC K95
K114-ub
TDLHVNPkkQTIGNs
0 1
EIF5 (human) TDLHVNPkkQTIGNs K114-ub
EIF5 (mouse) TDLHVNPKKQTIGNS K114
EIF5 (rat) TDLHVNPKKQTIGNS K114
K115-ub
DLHVNPkkQTIGNsC
0 1
EIF5 (human) DLHVNPkkQTIGNsC K115-ub
EIF5 (mouse) DLHVNPKKQTIGNSC K115
EIF5 (rat) DLHVNPKKQTIGNSC K115
S121-p
kkQTIGNsCKACGYR
0 1
EIF5 (human) kkQTIGNsCKACGYR S121-p
EIF5 (mouse) KKQTIGNSCKACGYR S121
EIF5 (rat) KKQTIGNSCKACGYR S121
T139-p
DTHHKLCtFILKNPP
0 1
EIF5 (human) DTHHKLCtFILKNPP T139-p
EIF5 (mouse) DTHHKLCTFILkNPP T139
EIF5 (rat) DTHHKLCTFILKNPP T139
K143
KLCtFILKNPPENsD
0 1
EIF5 (human) KLCtFILKNPPENsD K143
EIF5 (mouse) KLCTFILkNPPENSD K143-ub
EIF5 (rat) KLCTFILKNPPENSD K143
S149-p
LKNPPENsDsGTGKK
0 1
EIF5 (human) LKNPPENsDsGTGKK S149-p
EIF5 (mouse) LkNPPENSDIGtGKK S149
EIF5 (rat) LKNPPENSDIGTGKK S149
S151-p
NPPENsDsGTGKKEK
0 2
EIF5 (human) NPPENsDsGTGKKEK S151-p
EIF5 (mouse) NPPENSDIGtGKKEK I151
EIF5 (rat) NPPENSDIGTGKKEK I151
T153
PENsDsGTGKKEKEK
0 1
EIF5 (human) PENsDsGTGKKEKEK T153
EIF5 (mouse) PENSDIGtGKKEKEK T153-p
EIF5 (rat) PENSDIGTGKKEKEK T153
S174
DKENGSVSssEtPPP
1 0
EIF5 (human) DKENGSVSssEtPPP S174
EIF5 (mouse) DKENGSVSTSETPPP S174
EIF5 (rat) DKENGSVsTSETPPP S174-p
S175-p
KENGSVSssEtPPPP
0 1
EIF5 (human) KENGSVSssEtPPPP S175-p
EIF5 (mouse) KENGSVSTSETPPPP T175
EIF5 (rat) KENGSVsTSETPPPP T175
S176-p
ENGSVSssEtPPPPP
0 1
EIF5 (human) ENGSVSssEtPPPPP S176-p
EIF5 (mouse) ENGSVSTSETPPPPP S176
EIF5 (rat) ENGSVsTSETPPPPP S176
T178-p
GSVSssEtPPPPPPP
0 1
EIF5 (human) GSVSssEtPPPPPPP T178-p
EIF5 (mouse) GSVSTSETPPPPPPN T178
EIF5 (rat) GSVsTSETPPPPPPN T178
T207-p
DDDWGEDttEEAQRR
Upstream
1 0
Kinase, in vitro:
  • CK2A1 (human)
Treatment
  • serum
EIF5 (human) DDDWGEDttEEAQRR T207-p
EIF5 (mouse) DDDWGEDTTEEAQRR T205
EIF5 (rat) DDDWGEDTTEEAQRR T205
T208-p
DDWGEDttEEAQRRR
Upstream
1 0
Kinase, in vitro:
  • CK2A1 (human)
Treatment
  • serum
EIF5 (human) DDWGEDttEEAQRRR T208-p
EIF5 (mouse) DDWGEDTTEEAQRRR T206
EIF5 (rat) DDWGEDTTEEAQRRR T206
S220-p
RRRMDEIsDHAKVLt
0 2
EIF5 (human) RRRMDEIsDHAKVLt S220-p
EIF5 (mouse) RRRMDEIsDHAKGLT S218-p
EIF5 (rat) RRRMDEISDHAKGLT S218
T227-p
sDHAKVLtLsDDLER
0 7
EIF5 (human) sDHAKVLtLsDDLER T227-p
EIF5 (mouse) sDHAKGLTLsDDLER T225
EIF5 (rat) SDHAKGLTLsDDLER T225
S229-p
HAKVLtLsDDLERTI
0 24
EIF5 (human) HAKVLtLsDDLERTI S229-p
EIF5 (mouse) HAKGLTLsDDLERTV S227-p
EIF5 (rat) HAKGLTLsDDLERTV S227-p
K261-ub
GVIDSSDkEIVAEAE
0 1
EIF5 (human) GVIDSSDkEIVAEAE K261-ub
EIF5 (mouse) GIIDSSDKEIVAEAE K259
EIF5 (rat) GIIDSSDKDIVAEAE K259
K288-ub
TEVLFNEkIREQIKK
0 2
EIF5 (human) TEVLFNEkIREQIKK K288-ub
EIF5 (mouse) TEVLFDEKIREQIKK K286
EIF5 (rat) TEVLFDEKIREQIKK K286
Y362-p
SEKASKKyVSKELAk
0 2
EIF5 (human) SEKASKKyVSKELAk Y362-p
EIF5 (mouse) SEKASKKyVSKELAK Y360-p
EIF5 (rat) SEKASKKYVSKELAK Y360
K369-ac
yVSKELAkEIRVKAE
0 1
EIF5 (human) yVSKELAkEIRVKAE K369-ac
EIF5 (mouse) yVSKELAKEIRVKAE K367
EIF5 (rat) YVSKELAKEIRVKAE K367
S389-p
LKEAEEEssGGEEED
Upstream
Downstream
3 95
Effects on Modified Protein
  • molecular association, regulation
Effects on Biological Processes:
  • cell cycle regulation
  • translation, altered
Kinase, in vitro:
  • CK2A1 (human)
Putative in vivo kinases:
  • CK2A1 (human)
Treatment
  • serum
EIF5 (human) LKEAEEEssGGEEED S389-p
EIF5 (mouse) LKEAEEEssGGEEED S387-p
EIF5 (rat) LKEAEEEssGGEEED S387-p
S390-p
KEAEEEssGGEEEDE
Upstream
Downstream
3 96
Effects on Modified Protein
  • molecular association, regulation
Effects on Biological Processes:
  • cell cycle regulation
  • translation, altered
Kinase, in vitro:
  • CK2A1 (human)
Putative in vivo kinases:
  • CK2A1 (human)
Treatment
  • serum
EIF5 (human) KEAEEEssGGEEEDE S390-p
EIF5 (mouse) KEAEEEssGGEEEDE S388-p
EIF5 (rat) KEAEEEssGGEEEDE S388-p
Y405-p
DENIEVVysKAAsVP
Upstream
0 36
Treatment
  • gefitinib
  • Su11274
EIF5 (human) DENIEVVysKAAsVP Y405-p
EIF5 (mouse) DENIEVVysKTAsVP Y403-p
EIF5 (rat) DENIEVVYSKTASVP Y403
S406-p
ENIEVVysKAAsVPK
0 3
EIF5 (human) ENIEVVysKAAsVPK S406-p
EIF5 (mouse) ENIEVVysKTAsVPK S404-p
EIF5 (rat) ENIEVVYSKTASVPK S404
S410-p
VVysKAAsVPKVEtV
0 10
EIF5 (human) VVysKAAsVPKVEtV S410-p
EIF5 (mouse) VVysKTAsVPKVETV S408-p
EIF5 (rat) VVYSKTASVPKVETV S408
T416-p
AsVPKVEtVKsDNKD
0 1
EIF5 (human) AsVPKVEtVKsDNKD T416-p
EIF5 (mouse) AsVPKVETVKsDNKD T414
EIF5 (rat) ASVPKVETVKsDNKD T414
S419-p
PKVEtVKsDNKDDDI
Upstream
0 22
Treatment
  • nocodazole
EIF5 (human) PKVEtVKsDNKDDDI S419-p
EIF5 (mouse) PKVETVKsDNKDDDI S417-p
EIF5 (rat) PKVETVKsDNKDDDI S417-p